NANCY GILLIAM: Open Payments
NPI 1245278464 · PHILLIPSBURG, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 27 payments from 8 companies in 2025. Trend: 2023 $312 · 2024 $130 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $162 |
| Gilead Sciences, Inc. | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $116 |
| AstraZeneca Pharmaceuticals LP | 1 | $93 |
| Kestra Medical Technology Services, Inc. | 2 | $72 |
| PFIZER INC. | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $27 |
Products named: LEQVIO, Livdelzi, REZDIFFRA, LOKELMA, Assure WCD, ELIQUIS, JARDIANCE, LifeVest.
Industry payments across NJ — which companies pay providers there.
